Provided by Tiger Trade Technology Pte. Ltd.

Akari Therapeutics PLC

7.87
+0.40005.35%
Volume:30.41K
Turnover:240.31K
Market Cap:15.32M
PE:-0.49
High:8.10
Open:7.97
Low:7.69
Close:7.47
52wk High:49.60
52wk Low:3.02
Shares:1.95M
Float Shares:694.50K
Volume Ratio:0.81
T/O Rate:4.38%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-15.9015
EPS(LYR):-20.5537
ROE:-140.09%
ROA:-19.10%
PB:0.82
PE(LYR):-0.38

Loading ...

European Equities Traded in the US as American Depositary Receipts Head Lower in Tuesday Trading

MT Newswires Live
·
Aug 18

Akari Therapeutics - Ph1 Payload Shows Potential to Overcome Payload-Specific Resistance

THOMSON REUTERS
·
Aug 18

Akari Therapeutics - Aktx-101 Demonstrates Robust Anti-Tumor Activity in Urothelial Cancer Preclinical Models

THOMSON REUTERS
·
Aug 18

Akari Therapeutics - Continues to Advance Ind-Enabling Activities for Aktx-101 with Goal of Initiating Phase 1 Clinical Trial in Mid-2027

THOMSON REUTERS
·
Aug 18

Akari Therapeutics - Developing Aktx-102 ADC Targeting Ceacam5 in Multiple Solid Tumors

THOMSON REUTERS
·
Aug 18

Akari Therapeutics Says AKTX-101 Shows Anti-Tumor Activity in Preclinical Urothelial Cancer Models

Reuters
·
Aug 18

European Equities Traded in the US as American Depositary Receipts Open Week Higher in Monday Trading

MT Newswires Live
·
Aug 17

European Equities Traded in the US as American Depositary Receipts Track Lower in Friday Trading

MT Newswires Live
·
Aug 14

UK's Akari Therapeutics Q2 Net Loss Widens on Higher R&D for AKTX-101

Reuters
·
Aug 14

Akari Therapeutics PLC Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 14

Akari Therapeutics Reports Second Quarter 2026 Financial Results and Highlights Progress of Aktx-101 Towards Phase 1 and Strategic Collaboration for Its ADC Payload Platform

THOMSON REUTERS
·
Aug 14

Press Release: Akari Therapeutics Reports Second Quarter 2026 Financial Results and Highlights Progress of AKTX-101 Towards Phase 1 and Strategic Collaboration for Its ADC Payload Platform

Dow Jones
·
Aug 14

Akari Net Loss Widens to $4.81 Million in Q2 FY26; Operating Loss Rises to $4.6 Million

Reuters
·
Aug 14

European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading

MT Newswires Live
·
Aug 11

European Equities Traded in the US as American Depositary Receipts Edge Higher in Monday Trading

MT Newswires Live
·
Aug 10

Akari Therapeutics PLC Expected to Post a Loss of $1.40 a Share - Earnings Preview

Reuters
·
Aug 08

Akari Therapeutics Enters Research Collaboration with WhiteHawk Therapeutics on Dual-Payload ADCs

Reuters
·
Aug 04

European Equities Traded in the US as American Depositary Receipts Decline in Monday Trading

MT Newswires Live
·
Aug 03

European Equities Traded in the US as American Depositary Receipts Track Sharply Higher in Thursday Trading

MT Newswires Live
·
Jul 30

European Equities Traded in US as ADRs Ease in Wednesday Trading

MT Newswires Live
·
Jul 29